METASTASIS OF RENAL CANCER TO BREAST: DESCRIPTION OF CLINICAL CASE

Author:

Chernova E. V.1ORCID,Khaylenko V. A.2,Zhukova L. G.3,Abdullaev A. G.3,Komov D. V.3,Lyubchenko L. N.3,Khaylenkо A. V.2,Kudashkin N. E.4,Burov D. A.3

Affiliation:

1. Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

2. Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

3. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

4. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Department of Oncology and Radiation Therapy the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Abstract

The main method of treatment of local stages of clear cell renal cancer is surgical. The question of conducting adjuvant irradiation and chemotherapy after radical operations is open. Patients with solitary distant metastases and a favorable prognosis may become candidates for surgical treatment. Surgical removal of isolated solitary metastases allows to achieve 35–60  % of 5-year overall survival. The patient, observed in N.N.  Blokhin National Medical Research Center of Oncology with metastasis of renal cancer in the pancreas, and then in the breast is an extremely rare clinical case presented in this article.

Publisher

Publishing House ABV Press

Subject

Urology,Nephrology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference15 articles.

1. Malignant tumors inRussia in 2015 (morbidity and mortality).Eds.: А.D. Kaprin, V.V. Starinskiy,G.V. Petrova. Moscow: MNIOIim. P.A. Gertsena – filial FGBU “NMIRTS”Minzdrava Rossii, 2017. 250 p. (In Russ.).

2. Dimitriadis J., Bamias A. Adjuvant therapyin renal-cell carcinoma: Is it prime timeyet? Translat Cancer Res 2017;6(2):360–2.

3. Wahner-Roedler D.L., Sebo T.J. Renal cellcarcinoma: diagnosis based on metastatic manifestations. Mayo Clin Proc1997;72(10):935–41. PMID: 9379697.

4. Falco G., Buggi F., Sanna P.A. et al. Breast metastases from a Renal Cell Carcinoma. A case report and review of the literature. Int J Surg Case Rep 2014;5(4):193–5. DOI: 10.1016/j.ijscr.2014.01.019. PMID: 24632302.

5. Sindoni A., Rizzo M., Tuccari G. et al. Thyroid metastases from renal cellcarcinoma: review of the literature. Scientific World Journal 2010;10:590–602. DOI: 10.1100/tsw.2010.55.PMID: 20364245.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3